Tag: intracranial aneurysm

In light of recently presented and generally positive findings from the COAST study, which deemed coiling to be safe in the treatment of small...

Hereditary Brain Aneurysm (HBA) Support—a patient-centred organisation providing support and resources for those affected by hereditary brain aneurysms—has announced its new status as a...

This advertorial is sponsored by WallabyPhenox. Ahead of the COATING study’s much-anticipated final analyses, principal investigator Laurent Pierot (Reims University Hospitals, Reims, France) sits down...

Coil embolisation of smaller intracranial aneurysms—those less than 5mm in size—has been found to be a safe approach, as per data presented for the...

There is a potential connection between a diagnosis of certain gastrointestinal (GI) syndromes, and the formation and rupture of intracranial aneurysms, according to research presented...

Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the LVIS EVO intraluminal support device is now commercially available for the treatment...

This advertorial, intended for readers outside the USA only, is sponsored by Medtronic. In light of the official European launch of the Artisse aneurysm embolisation...

Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...

Intracranial aneurysms are a largely underestimated condition, for which global awareness and clinical research are currently lacking—and these sentiments apply even more pertinently when...

A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one...

Imperative Care has announced the initiation of a first-in-human (FIH) clinical study for its novel stent system designed to only require single antiplatelet therapy...

In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm...

A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in...

The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...

The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or...

The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact...

Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...

Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...

The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms...

Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms....

A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...

The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...

A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery...

Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...

A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured...

A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe...

Researchers in the USA have developed an injectable, ‘toothpaste-like’ biomaterial that may offer promise in the treatment of intracranial aneurysms as an alternative to...

A multicentre study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of renin-angiotensin-aldosterone system (RAAS) inhibitors—a...

Fresh data from the CERUS study—the first multicentre clinical trial evaluating safety and effectiveness outcomes with the Contour neurovascular system (Cerus Endovascular)—have indicated “encouraging...

Wallaby Medical has partnered with Japan Lifeline (JLL) to bring its Pharmaceuticals and Medical Devices Agency (PMDA)-approved Avenir coil system to the Japanese market....

The Diversion-p64 study—the largest prospective study using the p64 flow modulation device (phenox) to date—has demonstrated that the device has a high level of...

Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...

This year’s Congress of the European Society of Minimally Invasive Neurological Therapy (ESMINT 2021; 8–10 September, Nice, France and virtual) saw details of the...

Multiple pieces of clinical research supporting the use of flow diverter devices to treat intracranial aneurysms have come to light so far in 2021....

Fluid Biotech, a medical device start-up company based in Calgary, Canada, has announced the completion of an oversubscribed seed fundraising round totalling US$4.7 million—and...

The Flow Redirection Endoluminal Device stent system (FRED; MicroVention)—a flow diverter used to treat intracranial aneurysms—has been deemed safe and effective for this indication,...

The endovascular treatment of intracranial aneurysms using the Pipeline Embolization Device (PED; Medtronic) has been deemed safe and effective following a study involving data...

Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and...

  Stryker announced that it has received US Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas stent system as...

Mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased in the past decade, according to new findings presented at the Society of...

  phenox has announced the European launch of the new p64 MW Flow modulation device, intended for the treatment of intracranial aneurysms. The device received...

Cerus Endovascular has received CE Mark approval for its 0.021-inch Contour neurovascular system, compatible with smaller commercially available 021 microcatheters for the treatment of...

Cerus Endovascular has announced that it has received CE mark approval for its Neqstent Coil Assisted Flow Diverter device. The flow diverter is designed...

Cerus Endovascular has received CE mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The system incorporates...

MicroVention, a US based subsidiary of Terumo and a global neurovascular company announced the US FDA premarket approval (PMA) for the FRED (Flow re-direction...

Perflow Medical has announced they have received CE Mark approval for the Cascade Agile non-occlusive remodelling net (Cascade Agile). Expanding the Cascade product family,...

Phenox announces that it has signed an exclusive distribution agreement with Wallaby Medical for commercialisation of the Avenir Detachable Coil System in the US...

Mika Niemelä (Helsinki, Finland) talks to BLearning Neuro about the ‘Decision making in unruptured aneurysms’ session he chaired at ESMINT 2019 (European Society of Minimally Invasive Neurological Therapy;...

Three-year outcomes of the Surpass intracranial aneurysm embolisation system pivotal trial to treat large or giant wide neck aneurysm (SCENT trial) confirm the safety...

Stryker has announced the premarket approval (PMA) of the Neuroform Atlas stent system by the US Food and Drug Administration (FDA). Neuroform Atlas—according to the...

Cerus Endovascular has announced enrolment of the first patients in the CERUS study (Contour Neurovascular System European Pre-Market Unruptured Aneurysm Study). The CERUS study...

Acandis has announced that it has received European CE mark approval for its ACCERO stent, which is now available for sale in Europe. The...

Cerenovus, part of the Johnson & Johnson Medical Devices Companies, has announced that the first patients have been treated with the BRAVO Flow Diverter,...

The US Food and Drug Administration has approved the Neuroform Atlas Stent System (Stryker) for marketing under a humanitarian device exemption (HDE). The device...

Cerus Endovascular has provided an update on its lead development programmes, including the Contour Neurovascular System as well as the NEQSTENT Intra-Saccular Stent. “The past...

Based on a sub-analysis of the data from the prospective Target aneurysm multicentre registry, the coiling of aneurysms <5mm in size with Target coils...

The Contour Neurovascular System (Cerus Endovascular) has received CE mark approval for the treatment of intracranial aneurysms. Contour is a unique, fine mesh braid...

The first patients have been enrolled and treated in a prospective, single-arm, multicentre study evaluating the Contour Neurovascular System (Cerus Endovascular). Used for the...

A single-centre study reports that stent-assisted coiling with the Barrel stent (Medtronic) is a feasible, safe, and efficient method for embolisation of intracranial wide-necked...

The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...

By Andreas MJ Frölich Endovascular aneurysm therapy today is characterised by a rapidly growing and evolving collection of available treatment devices. The challenge in achieving...

A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal...

According to a report of a single centre’s experience using the Medina embolisation device (Medtronic) for the treatment of unruptured aneurysms, the device “represents...

Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term...

In the ANSWER (Adjunctive neurovascular support of wide-neck aneurysm embolization and reconstruction) study of the PulseRider device (Pulsar Vascular), enrolment, 30-day and 180-day follow-up...

Find the latest updates from Prof Monika Killer and Dr Saleh Lamin following this year’s LINNC Congress in Paris. We consider our latest technologies,...

The Contour Neurovascular System (Cerus Endovascular) will offer a new option for treating intracranial aneurysms. According to Kyriakos Lobotesis, Principle Clinical Advisor at Cerus,...

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolisation device. The purchase price...

Medina™ is designed as an intra-saccular flow diverter, diverting flow away from the aneurysm sac and through the parent artery by forming a mesh scaffold...

The results of a multicentre study have shown that catherisation with the larger profile coil delivery microcatheter and aneurysm occlusion with large volume coils...

Sequent Medical has begun enrolling patients in a study which will evaluate the safety and effectiveness of the WEB (woven endobridge) aneurysm embolisation system...

At the 2015 annual meeting of the European Society of Minimally Invasive Neurological Therapy (ESMINT; 10–12 September, Nice, France) Gyula Gal (Department of Radiology,...

The Barrel Vascular Reconstruction device (Medtronic) is one of the newest offerings for the treatment of intracranial bifurcation aneurysms. Since receiving the CE mark...

Pulsar Vascular has announced that they have reached the target enrolment in their clinical trial for PulseRider device for the treatment of intracranial aneurysms....

In the first study to be published reporting on endovascular aneurysm treatment with the p64 flow modulation device (Phenox), Francesco Briganti and colleagues have found that the device provides a safe procedure with no technical complications.

Phenox GmbH has announced the start of the pToWin study after enrolling the first patient on 2 September, 2015. The prospective, multicentre, single-arm study...

Medtronic plc has announced that it has acquired Medina Medical, a Menlo Park, California, USA-based and privately-held medical device company focused on commercialising state-of-the-art...

According to new research, treatment of large and giant proximal internal carotid artery aneurysms using the Pipeline embolisation device (Covidien/Medtronic) requires less radiation, less...

Sequent Medica has announced the presentation of prospective long-term clinical data for the WEB aneurysm embolisation system at the Societe Francaise de Neuroradiologie (SFNR)...

In early use of the Medina coil system, researchers have found the device to be a next generation coil that combines the familiar procedural safety and technique associated with conventional coils, with improved circumferential aneurysm filling, which, they say, it is thought will lead to improved long-term outcomes.

Designed to divert blood flow away from an aneurysm, the Pipeline Flex embolisation device (Medtronic) features a braided cylindrical mesh tube that is implanted across the base or neck of the aneurysm.

Initial experience with PulseRider (Pulsar Vascular) has shown the device to be safe and effective as an adjunct in the treatment of bifurcation aneurysms arising at the basilar apex or carotid terminus.

Medina Medical has announced that it has received CE mark authorisation for its Embolization Framing Coil for commercial distribution in the European Union.

PulseRider is a minimally invasive device intended for use with embolic coils in the treatment of unruptured wide-neck intracranial aneurysms originating on or near a bifurcation.

The IDE allows Pulsar Vascular to begin a multicentre clinical trial in support of a humanitarian device exemption (HDE) to evaluate the PulseRider for US approval for wide neck aneurysms at or near a bifurcation of the basilar tip or carotid terminus.

Pulsar Vascular announced that it has received European CE mark approval for Pulserider. This unique implant is used to bridge the neck of cerebral aneurysms previously not amenable to endovascular therapy. This new device is implanted via standard, minimally invasive, endovascular techniques thus providing an alternative treatment option to open surgery.

The pCONus implant for treatment of complex, wide neck intracranial bifurcation aneurysms has been granted the CE mark for commericalisation in Europe.

The p64 Flow Modulation Device is an intraluminal flow diverter for treatment of complex intracranial aneurysms and dissections.